Send2PressNewswire.com  •  Today is Thursday, February 23, 2012 Part of the Neotrope News Network Neotrope
Send2Press Newswire
All News Business Books Music Computing Education Medical Opinion Finance Travel Events VIDEOS
Calif.  |  Colorado  |  D.C.  |  Florida  |  Georgia  |  Illinois  |  Mass.  |  Missouri  |  New Jersey  |  New York  |  Okla.  |  Texas  |  Utah  |  Wash. State  |  All News Topics
JOURNALIST TOOLS Subscribe to News  |  Top RSS Feeds  |  Popular News  |  eMediaKit™ Company Profiles  | 

Whistleblower Scientist Accuses British Medical Journal of Institutional Research Misconduct

Actions of BMJ Editor and Reporter 'More Tabloid News than Science' According to Dr. David Lewis, and 'a Genuine Threat to Public Health.'
Email this Page Print-Friendly Page
Mon, 09 Jan 2012 05:58:29 -0500 EST

Dr. David LewisWASHINGTON, D.C., Jan. 9, 2012 (SEND2PRESS NEWSWIRE) — Dr. David Lewis, internationally known whistleblower and respected expert on institutional fraud, released a report today calling for a formal investigation into the practices of the British Medical Journal (BMJ), and specifically into the actions of its editor, Dr. Fiona Godlee, and Brian Deer, a reporter she hired to write a series of articles which appeared in the journal beginning on January 4, 2011.

The BMJ articles accuse Dr. Andrew Wakefield of committing scientific fraud in a 1998 Lancet publication – http://www.thelancet.com/journals/lancet/article/PIIS0140673697110960/fulltext – he co-authored that brought global attention to a link many parents and physicians suspect may exist between autism and children who are genetically predisposed to adverse reactions from the Measles/Mumps/Rubella (MMR) vaccine.

The BMJ, Deer, and Godlee alleged that Wakefield fabricated a diagnosis of colitis in most of the 12 children described in The Lancet article – calling Wakefield’s work an “elaborate fraud” intended to create an “MMR scare” – so Wakefield could profit from a patent related to his research.

“Documents recovered from Dr. Wakefield’s files during my investigation at the National Whistleblowers Center (NWC) – www.researchmisconduct.org – reveal that a pathologist associated with the study, Dr. Andrew Anthony, interpreted a number of the children’s biopsies as evidence of colitis,” explained Dr. Lewis. “Altogether, the evidence contained in Wakefield’s files suggested to me that the BMJ’s fraud theory was more tabloid news than science.”

According to documents Lewis filed with Sir John Tooke, Vice-Provost for Health at the University College London (UCL) where The Lancet study was done, BMJ Editor Godlee responded to the Lewis revelations by “cherry-picking the evidence and coming up with a grand conspiracy theory involving ‘institutional research misconduct’. Alleged fraudsters now include University College London (UCL) administrators, the Royal Free Hospital, and all 13 co-authors of the Lancet study.”

UCL President Malcolm Grant notified Lewis that, because his charges were “so serious,” he urged Dr. Lewis to inform Dr. Godlee and Deer “at the earliest opportunity.”

Lewis also reports that Godlee has previously acknowledged the BMJ Group receives funding from the two manufacturers of the MMR vaccine, Merck and GlaxoSmithKline, and has testified in a Parliamentary inquiry that peer-reviewed medical journals are “the marketing arm of the pharmaceutical industry.” Lewis added: “Apparently scientists who question certain government policies and industry practices can be destroyed for a price. If so, this kind of tabloid science poses a genuine threat to public health.”

On January 3, 2012, Dr. Wakefield filed suit against the BMJ and Brian Deer ( http://www.courthousenews.com/2012/01/04/BritMedJ.pdf ). Last September, Columbia University published a major study supporting the link Dr. Wakefield established between autism and enterocolitis ( http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174969/ ).

Lewis Investigation Available Online:
Dr. Lewis’ detailed investigation of the BMJ series in question can be downloaded from the following URL provided by his attorneys at Hallman & Wingate, LLC:

http://www.hallmanwingate.com/fullpanel/uploads/files/david-lewis-bmj.pdf .

About Dr. David Lewis:
Dr. David Lewis, a member of the NWC Board of Directors and Director of its Research Misconduct Project, is a former senior-level research microbiologist for the U.S. Environmental Protection Agency (EPA). He was the only EPA scientist to ever publish first-authored research articles in Lancet and Nature. His research published in Lancet and Nature Medicine on the inadequacy of CDC guidelines to prevent transmission of HIV in dentistry prompted the current heat sterilization standard for dentistry in the mid-1990s. His environmental research published in Nature received the Science Achievement Award by the EPA Administrator in 2000. Editors at Annals of Internal Medicine rated him in the top 10 percent of reviewers in 2010. His accomplishments in medical and environmental research have been widely covered in professional, scientific and popular publications and broadcasts including Nature, Science, Lancet, JAMA, National Geographic, Reader’s Digest, Voice of America, Paul Harvey News, Time, Newsweek, U.S. News & World Report, Forbes, NY Times, Washington Post, London Times, NPR’s All Things Considered, PBS Healthweek, PBS Technopolitics, CBS Evening News, ABC’s Primetime Live, and BBC Panorama.

Dr. Lewis’s direct contact information: (706) 296 3675, LewisDaveL@aol.com .

About the BMJ:
The British Medical Journal is a highly regarded, peer-reviewed scientific journal. BMJ is sent to more than 100,000 doctors internationally, many of whom have stakes in vaccine usage.

Media Contact:
Elizabeth Horn
Horn Productions
650-685-0435
elizabeth@hornproductions.net .

News Source: Dr. David Lewis :: This press release was issued on behalf of the news source by Send2Press® Newswire, a service of Neotrope®. View all current news at: http://Send2PressNewswire.com .


Some rights reserved - attribution required This press release is Copr. © 2012 Dr. David Lewis and Send2Press®. Rights granted for re-publication by media and aggregators provided original source retained.
This press release has had 693 views so far.
Important Note about Press Release: for questions or clarification about any information in the above press release, contact the person/company mentioned in the release and NOT this Web site. Send2Press Newswire is a wire service and cannot assist you with information regarding any person, product, company or opinion expressed or mentioned in the above press release which has been provided by the news source.

TERMS OF USE AND LICENSE: This "article" version of the issued press release is Copr. © 2012 by Neotrope/Send2Press. You may freely link to this article version of the press release, and/or legitimate media may use the release text (note link to plain text UTF-8 version) as the basis for an original article or news posting except where it might violate our copyrights or the Terms of Use. If the content is copied verbatim via a scraping or copy/paste method on a news portal, the news item must be properly "attributed" to Send2Press® Newswire as the originating wire service for this story with link back to original permalink (this page). CLICK HERE to view Legal Statement for this site.

IMPORTANT: Content expressly MAY NOT be used on any competing "newswire service", be used with our newslines removed as if to appear as original bylined content on another portal, and may NEVER be used on any site, service, portal or archive which sells press release services, news distribution/posting, free news posting, public relations representation, PR writing, or similar competitive offerings to Send2Press® Newswire. Such violations of our legal rights and those of our clients will be addressed via DMCA and the hosting provider(s) of the offending web properties, as applicable. Content may be used provided original newsline is kept intact (SEND2PRESS NEWSWIRE) and our copyright notice at bottom of each story is retained. Use of our content for commercial purposes without express permission is forbidden.

DISCLAIMER: the above press release content is believed accurate but not guaranteed, and is based on business news supplied by the "news source." The noted source is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements. Neotrope/Send2Press (this Web site) makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news and profiles are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope® or the Send2Press® Newswire service. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. All trademarks acknowledged.



 
Latest Press Releases from Send2Press Newswire:
 
Send2Press® Newswire content by Categories, Topics, and Locales